Search

Your search keyword '"Pecorelli S"' showing total 842 results

Search Constraints

Start Over You searched for: Author "Pecorelli S" Remove constraint Author: "Pecorelli S"
842 results on '"Pecorelli S"'

Search Results

1. Scaling up health knowledge at European level requires sharing integrated data: an approach for collection of database specification

2. Interventional tools to improve medication adherence: review of literature

3. Erratum to: Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA

7. A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer

9. Effects of irradiation on the expression of surface antigens in human ovarian cancer.

10. Effects of cytokines combined with high-dose gamma irradiation on the expression of major histocompatibility complex molecules and intercellular adhesion molecule-1 in human ovarian cancers.

11. Development and characterization of an interleukin-2-transduced human ovarian carcinoma tumor vaccine not expressing major histocompatibility complex molecules.

12. Development and in vitro characterization of a GM-CSF secreting human ovarian carcinoma tumor vaccine.

13. Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA

19. 2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004)

23. Carcinoma of the Ovary

29. HPV Vaccination Concepts in the Reality of Today

33. Cisplatin, doxorubicin and ifosfamide in carcinosarcoma of the female genital tract. A phase II study of the European Organization for Research and Treatment of Cancer Gynaecological Cancer Group (EORTC 55923)

36. Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials

39. Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA

40. Molecular basis of pharmacological therapy in Cushing’s disease

42. Building Bridges for Innovation in Ageing : Synergies between Action Groups of the EIP on AHA

43. Building bridges for innovation in ageing:synergies between action groups of the EIP on AHA

44. Building Bridges for Innovation in Ageing: Synergies between Action Groups of the EIP on AHA.

45. BUILDING BRIDGES FOR INNOVATION IN AGEING: SYNERGIES BETWEEN ACTION GROUPS OF THE EIP ON AHA

46. Building Bridges for Innovation in Ageing:Synergies between Action Groups of the EIP on AHA

47. Building Bridges for Innovation in Ageing: Synergies between Action Groups of the EIP on AHA

48. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients

49. Treatment of skeletal impairment in patients with endogenous hypercortisolism: when and how?

50. Erratum to: Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA

Catalog

Books, media, physical & digital resources